Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - flucloxacillin, quantity: 500 mg - injection, powder for - excipient ingredients: - treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - flucloxacillin sodium monohydrate, quantity: 2176 mg (equivalent: flucloxacillin, qty 2000 mg) - injection, powder for - excipient ingredients: - treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 500 mg - the penicillinase-resistant penicillins are indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs. cultures and susceptibility tests should be performed initially to determine the causative organism and their sensitivity to the drug (see clinical pharmacology – susceptibility testing ). the penicillinase-resistant penicillins may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results. the penicillinase-resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g. if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus, therapy should not be continued with a penicillinase-resistant penicillin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dic

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - flucloxacillin sodium - capsule, hard - 500 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - flucloxacillin sodium - oral capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - flucloxacillin sodium - oral capsule - 500mg

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - flucloxacillin sodium - film-coated tablet - flucloxacillin

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - flucloxacillin sodium - film-coated tablet - flucloxacillin

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - ampicillin as the sodium salt; cloxacillin as sodium monohydrate salt - misc. intra mammary - ampicillin as the sodium salt antibiotic active 75.0 mg/5gsyr; cloxacillin as sodium monohydrate salt antibiotic active 200.0 mg/5gsyr - antibiotic & related - dairy cattle lactating | bovine | milking cow - antibiotic - anti-infective | antibiotics - oral, parenteral | arcanobacterium spp. | bacterial infection | corynebacterium spp. | escherichia coli (e. coli) | mastitis | organisms sensitive to cloxacillin | staphylococcus spp. | streptococcus agalactiae | streptococcus spp. | abrasions | abscesses | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | antiseptic | associated with viral disease | avian mycoplasmas | bacterial canker | blackhead | body odours | bowed tendons | broad spectrum | burns | clavulanic acid sensitive | coccidiosis | coliform complex | conjunctivitis | coryza | cowpox | cracks | crd | crusts | dandruff | dermatological disorders | dermatoses | dermatosis | diarrhoea | dry skin | dysentery | eczema | endometritis | enteric diseases | enteritis | enzootic pneumonia | escherichia coli | european brood disease | feed efficiency | fungal infections | gentamicin sensitive | girth galls | gram negative organisms | gram positive organisms | hypermotility | includin

Malta - English - Medicines Authority

novelgenix therapeutics limited 20, oliver business park, oliver road, park royal, london, nw10 7jb, united kingdom - flucloxacillin sodium - powder for oral solution - flucloxacillin sodium 250/5 milligram(s) - antibacterials for systemic use